Evolve BioSystems, Inc. announces Dr. Minhthy Nguyen as Senior Vice President of Research & Development, further advancing its position as the leader in infant gut health

DAVIS, Calif., July 28, 2020 /PRNewswire/ -- Evolve BioSystems announced today that Dr. Minhthy Nguyen, PhD, has joined the company as Senior Vice President, Research & Development. Dr. Nguyen joins the company in anticipation of the pending announcement of positive results from several large clinical studies, positioning the company for a material leap forward in the infant health space.

Dr. Nguyen is a veteran of the infant nutrition industry with an extensive background that includes leadership positions at Abbott Nutrition and Dupont Nutrition & Health. Since 2016, he has served as Vice President, Global Innovation & Scientific Affairs, and The Americas R&D at Mead Johnson Nutrition (now Reckitt Benckiser). Dr. Nguyen is a graduate of University of California, Davis, where he earned a BS in Biochemistry, as well as The Ohio State University where he earned his doctorate in Food Science and Nutrition.

"I am thrilled to join Evolve on three fronts. First, the scope and magnitude of our organization's potential to impact global infant health is both inspiring and humbling. Second, the strength of our breakthrough science via research collaborations with world-renowned institutions and investigators is unrivaled and more importantly, unique in elucidating the critical role of activated B. infantis EVC001 (Evivo ®). Finally, the opportunity to be a member of the Evolve team, one that continues to pioneer the betterment of infant health through resolving infant gut dysbiosis, is not only a privilege but also an honor," says Dr. Nguyen.

Tim Brown, Evolve BioSystems's CEO, states, "It has been a great pleasure building this company from early launch of our first infant products to where we are today, now with millions of feedings of Evivo to newborns. Having Minhthy bring his deep expertise in infant nutrition research and product development at this inflection point of our company significantly bolsters our ability to improve the lifetime health trajectory of babies worldwide."

About Evolve BioSystems, Inc.

Evolve BioSystems, Inc. is a privately held microbiome company dedicated to researching solutions to establish, restore, and maintain a healthy gut microbiome. Evolve is a portfolio company of the Bill & Melinda Gates Foundation and Horizons Ventures, the venture division of the Li Ka Shing Foundation. Evolve is a spin-off from the Foods for Health Institute (FFHI) at the University of California, Davis and builds on more than a decade of research into understanding the unique partnership of the infant gut microbiome and breast milk components.

SOURCE Evolve BioSystems